Literature DB >> 9059843

In vivo vulnerability of dopamine neurons to inhibition of energy metabolism.

G D Zeevalk1, L Manzino, J Hoppe, P Sonsalla.   

Abstract

In vitro studies indicate that mesencephalic dopamine neurons are more vulnerable than other neurons to impairment of energy metabolism. Such findings may have bearing on the loss of dopamine neurons in Parkinson's disease, in which mitochondrial deficiencies have been identified, but would only be relevant if the selective vulnerability were maintained in vivo. To examine this, rats were stereotaxically administered various concentrations of the succinate dehydrogenase inhibitor, malonate (0.25-4 mumol), either into the left substantia nigra or striatum. One week following injection, dopamine and gamma-aminobutyric acid (GABA) levels in the mesencephalon and striatum were measured. Intranigral injection of malonate caused nigral dopamine and GABA to be comparably reduced at all doses tested. The 50% dose level for malonate vs. dopamine and GABA loss was 0.39 and 0.42 mumol, respectively. Tyrosine hydroxylase immunocytochemistry of the midbrains of rats which received an intranigral injection of malonate showed normal staining with 0.25 mumol malonate, but almost complete loss of tyrosine hydroxylase positive nigral pars compacta cells with 1 mumol malonate. Intrastriatal injection of malonate produced a loss of both tyrosine hydroxylase activity and dopamine. In contrast to what was seen in substantia nigra, there was a greater loss of dopamine than GABA in striatal regions nearest the injection site. In striatal regions most distal to the injection site, and which received the lowest concentration of malonate due to diffusion, dopamine levels were significantly reduced with all doses of malonate (0.5-4 mumol), whereas GABA levels were unaffected. Intrastriatal coinfusion of succinate along with malonate completely prevented the loss of dopamine and GABA indicating that succinate dehydrogenase inhibition was the cause of toxicity. These findings indicate that dopamine terminals in the striatum of adult rats are selectively more vulnerable than are the GABA neurons to a mild energy impairment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059843     DOI: 10.1016/s0014-2999(96)00892-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Na(+)/H(+) exchanger inhibition modifies dopamine neurotransmission during normal and metabolic stress conditions.

Authors:  Marcelo A Rocha; David P Crockett; Lai-Yoong Wong; Jason R Richardson; Patricia K Sonsalla
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

2.  The Mammalian Malonyl-CoA Synthetase ACSF3 Is Required for Mitochondrial Protein Malonylation and Metabolic Efficiency.

Authors:  Caitlyn E Bowman; Susana Rodriguez; Ebru S Selen Alpergin; Michelle G Acoba; Liang Zhao; Thomas Hartung; Steven M Claypool; Paul A Watkins; Michael J Wolfgang
Journal:  Cell Chem Biol       Date:  2017-05-04       Impact factor: 8.116

3.  Analysis of regional brain mitochondrial bioenergetics and susceptibility to mitochondrial inhibition utilizing a microplate based system.

Authors:  Andrew Sauerbeck; Jignesh Pandya; Indrapal Singh; Kevin Bittman; Ryan Readnower; Guoying Bing; Patrick Sullivan
Journal:  J Neurosci Methods       Date:  2011-03-23       Impact factor: 2.390

4.  Catecholamine neuron groups in rat brain slices differ in their susceptibility to excitatory amino acid induced dendritic degeneration.

Authors:  P T Bywood; S M Johnson
Journal:  Neurotox Res       Date:  2001-11       Impact factor: 3.911

5.  Engrailed-2 (En2) deletion produces multiple neurodevelopmental defects in monoamine systems, forebrain structures and neurogenesis and behavior.

Authors:  Matthieu Genestine; Lulu Lin; Madel Durens; Yan Yan; Yiqin Jiang; Smrithi Prem; Kunal Bailoor; Brian Kelly; Patricia K Sonsalla; Paul G Matteson; Jill Silverman; Jacqueline N Crawley; James H Millonig; Emanuel DiCicco-Bloom
Journal:  Hum Mol Genet       Date:  2015-07-28       Impact factor: 6.150

Review 6.  Role of the malonyl-CoA synthetase ACSF3 in mitochondrial metabolism.

Authors:  Caitlyn E Bowman; Michael J Wolfgang
Journal:  Adv Biol Regul       Date:  2018-09-05

7.  Rethinking energy in parkinsonian motor symptoms: a potential role for neural metabolic deficits.

Authors:  Shinichi Amano; Deborah Kegelmeyer; S Lee Hong
Journal:  Front Syst Neurosci       Date:  2015-01-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.